Meilan Zhang Selected Research

Meilan Zhang Research Topics

Disease

13	Neoplasms (Cancer) 01/2024 - 11/2016
3	Stomach Neoplasms (Stomach Cancer) 07/2023 - 10/2022
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 02/2018
3	Autoimmune Diseases (Autoimmune Disease) 03/2009 - 05/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2023 - 01/2021
2	Lymphoma (Lymphomas) 05/2023 - 05/2007
2	Carcinogenesis 10/2022 - 09/2022
2	Fibrosis (Cirrhosis) 10/2021 - 02/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021 - 02/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 05/2008
2	Philadelphia Chromosome 01/2021 - 02/2018
2	Liver Neoplasms (Liver Cancer) 01/2020 - 11/2016
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2019 - 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024
1	Cognitive Dysfunction 12/2023
1	Nasopharyngeal Carcinoma 05/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Leukemia 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Neuroblastoma 05/2022
1	Cytokine Release Syndrome 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Bone Marrow Failure Disorders 01/2022
1	Fanconi Anemia (Fanconi's Anemia) 01/2022
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022
1	Genomic Instability 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Asthma (Bronchial Asthma) 10/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Scrapie 12/2019
1	Hepatocellular Carcinoma (Hepatoma) 03/2018
1	Infections 01/2015
1	Medically Unexplained Symptoms 03/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2009
1	Skin Diseases (Skin Disease) 03/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2020
5	Circular RNAIBA 06/2023 - 12/2021
4	Long Noncoding RNAIBA 06/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 06/2023 - 12/2021
3	MicroRNAs (MicroRNA)IBA 06/2023 - 12/2021
2	EnzymesIBA 07/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 06/2023 - 05/2022
2	Competitive Endogenous RNAIBA 06/2023 - 10/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 09/2022
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
2	Prion ProteinsIBA 12/2019 - 01/2018
2	Monoclonal AntibodiesIBA 05/2008 - 05/2007
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	Sevoflurane (Ultane)FDA LinkGeneric 12/2023
1	Ketamine FDA LinkGeneric 12/2023
1	Neuroprotective AgentsIBA 12/2023
1	CalreticulinIBA 09/2023
1	Oxygen (Dioxygen)IBA 07/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2023
1	EBV-encoded nuclear antigen 1IBA 05/2023
1	CarcinogensIBA 05/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2023
1	NF-kappa B (NF-kB)IBA 05/2023
1	Chemokine ReceptorsIBA 05/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2023
1	TropomyosinIBA 01/2023
1	venetoclaxIBA 01/2023
1	larotrectinibIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	LuciferasesIBA 05/2022
1	Decitabine FDA Link 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	HomoharringtonineIBA 01/2022
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2021
1	atractylonIBA 10/2021
1	OvalbuminIBA 10/2021
1	indium-bleomycinIBA 02/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2021
1	AntigensIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	ginsenoside M1IBA 01/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2012
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 03/2009
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2009
1	LigandsIBA 03/2009

Therapy/Procedure

7	Therapeutics 01/2023 - 11/2016
4	Immunotherapy 09/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2023 - 12/2021
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Induction Chemotherapy 01/2022